Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Tablets

Approval Number

国药准字H20247123

Company苏州第三制药厂有限责任公司

Registration Date

June 7, 2024

Previous Approval Numbers

国药准字H20213398

Drug Information

Generic Name

利伐沙班片

Dosage Form

片剂

Strength

2.5mg

Drug Type

化学药品

Registration Date

June 7, 2024

Company Information

Applicant Company

Company Name苏州第三制药厂有限责任公司

Company Address

苏州市吴江区汾湖高新技术产业开发区金字路8号

Manufacturing Company

Company Name苏州第三制药厂有限责任公司

Company Address

苏州市吴江区汾湖高新技术产业开发区金字路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy